Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma
Clinical Laboratory · 2026 · 72 (05/2026)
DOI: 10.7754/clin.lab.2025.250554 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Haixia Li und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cuproptosis, Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Li, H., Cao, L., Li, R., Xu, L., Zhang, S., Gao, J., Chen, Y., & Lian, X. (2026). Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma. Clinical Laboratory, 72(05/2026). https://doi.org/10.7754/clin.lab.2025.250554
Vancouver
Li H, Cao L, Li R, Xu L, Zhang S, Gao J, et al. Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma. Clinical Laboratory. 2026;72(05/2026). doi:10.7754/clin.lab.2025.250554
BibTeX
@article{Li2026,
author = {Li, Haixia and Cao, Li and Li, Ruimin and Xu, Ling and Zhang, Shuxia and Gao, Jianjun and Chen, Yongxue and Lian, Xiaoqiang},
title = {Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {05/2026},
doi = {10.7754/clin.lab.2025.250554}
}
EUVIMED